BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1462 related articles for article (PubMed ID: 27836567)

  • 1. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.
    Raychaudhuri SP; Wilken R; Sukhov AC; Raychaudhuri SK; Maverakis E
    J Autoimmun; 2017 Jan; 76():21-37. PubMed ID: 27836567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
    Mease PJ; Armstrong AW
    Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics.
    Mease PJ; Gladman DD; Helliwell P; Khraishi MM; Fuiman J; Bananis E; Alvarez D
    J Am Acad Dermatol; 2014 Oct; 71(4):649-55. PubMed ID: 24974240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting.
    Chandran V; Gladman DD
    J Rheumatol; 2011 Mar; 38(3):546-7. PubMed ID: 21362783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study).
    Mishra S; Kancharla H; Dogra S; Sharma A
    Br J Dermatol; 2017 Mar; 176(3):765-770. PubMed ID: 27500901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.
    López Estebaránz JL; Zarco-Montejo P; Samaniego ML; García-Calvo C;
    Eur J Dermatol; 2015; 25(1):57-63. PubMed ID: 25333645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
    Elyoussfi S; Thomas BJ; Ciurtin C
    Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis.
    Lu C; Wallace BI; Waljee AK; Fu W; Zhang Q; Liu Y
    Semin Arthritis Rheum; 2019 Dec; 49(3):381-388. PubMed ID: 31272807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching biologics in the treatment of psoriatic arthritis.
    Merola JF; Lockshin B; Mody EA
    Semin Arthritis Rheum; 2017 Aug; 47(1):29-37. PubMed ID: 28363434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease.
    Helliwell P; Coates LC; FitzGerald O; Nash P; Soriano ER; Elaine Husni M; Hsu MA; Kanik KS; Hendrikx T; Wu J; Kudlacz E
    Arthritis Res Ther; 2018 Oct; 20(1):242. PubMed ID: 30373651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis.
    Kerschbaumer A; Smolen JS; Dougados M; de Wit M; Primdahl J; McInnes I; van der Heijde D; Baraliakos X; Falzon L; Gossec L
    Ann Rheum Dis; 2020 Jun; 79(6):778-786. PubMed ID: 32381564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New targets in psoriatic arthritis.
    Braun J
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii30-ii37. PubMed ID: 27856658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
    Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
    J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of disease activity measures for psoriatic arthritis: what is the best approach?
    Her M; Kavanaugh A
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.
    Gossec L; Coates LC; de Wit M; Kavanaugh A; Ramiro S; Mease PJ; Ritchlin CT; van der Heijde D; Smolen JS
    Nat Rev Rheumatol; 2016 Dec; 12(12):743-750. PubMed ID: 27829672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires.
    Haroon M; Kirby B; FitzGerald O
    Ann Rheum Dis; 2013 May; 72(5):736-40. PubMed ID: 22730367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriatic arthritis: current therapy and future approaches.
    Huynh D; Kavanaugh A
    Rheumatology (Oxford); 2015 Jan; 54(1):20-8. PubMed ID: 25125588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriatic arthritis.
    Ocampo D V; Gladman D
    F1000Res; 2019; 8():. PubMed ID: 31583079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis: A multicenter study.
    Cui R; Chen M; Li X; Wang Q; Tong Q; Zhang H; Chen Z; Tao YL; Bi XL; Deng H; Yuan DF; He DY; Ding YF; Dai SM
    J Dermatol; 2022 Jun; 49(6):615-623. PubMed ID: 35318711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Mease PJ; Boehncke WH; Gladman DD
    J Rheumatol; 2013 Aug; 40(8):1407-9. PubMed ID: 23908533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.